Skip to main content
. 2021 Sep 13:jfab087. doi: 10.1093/jalm/jfab087

Table 1.

Characteristics of study participants.

Characteristics All participants HCWs Transplant recipients
N 98 88 10
 Female, n (%) 65 (66) 62 (70) 3 (30)
 Male, n (%) 33 (34) 26 (30) 7 (70)
Age, median (range) 45 (22–84) 44 (22–82) 61 (42–84)
Pfizer-BioNTech BNT162b2
 Dose 1 only, n 39 39 0
 Dose 2, n 54 49 5
Moderna mRNA-1273
 Dose 1 only, n 0 0 0
 Dose 2, n 5 0 5